Quick Answer
Q32 Bio Inc. reported Operating Income of $16.90 million for fiscal year 2025.
Q32 Bio Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $16.90M | +125.6% |
| 2024 | -$66.10M | -37.0% |
| 2023 | -$48.26M | +63.8% |
| 2022 | -$133.28M | -38.9% |
| 2021 | -$95.95M | +26.3% |
| 2020 | -$130.26M | -18.5% |
| 2019 | -$109.94M | -83.5% |
| 2018 | -$59.93M | -102.1% |
| 2017 | -$29.66M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.58M | +59.7% | +17.4% |
| June 30, 2025 | -$9.17M | +48.8% | +25.0% |
| March 31, 2025 | -$12.23M | +17.6% | +35.0% |
| September 30, 2024 | -$18.81M | -141.3% | -5.0% |
| June 30, 2024 | -$17.92M | -146.3% | -20.7% |
| March 31, 2024 | -$14.84M | -101.3% | -90.3% |
| September 30, 2023 | -$7.80M | +76.3% | -7.2% |
| June 30, 2023 | -$7.28M | +74.3% | +1.3% |
- Q32 Bio Inc. showed an increase of +125.6% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Q32 Bio Inc.’s operating income has grown by 157.0% (from -$29.66 million to $16.90 million).
- The most recent figure is from Q32 Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: